Get the Stockscreener App
25.33
0.92%
0.23
After Hours:
25.33
Enovis Corp stock is traded at $25.33, with a volume of 430.50K.
It is up +0.92% in the last 24 hours and up +10.18% over the past month.
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.
See More
Previous Close:
$25.10
Open:
$25.07
24h Volume:
430.50K
Relative Volume:
0.42
Market Cap:
$1.46B
Revenue:
$2.25B
Net Income/Loss:
$-1.18B
P/E Ratio:
-1.2241
EPS:
-20.6926
Net Cash Flow:
$19.92M
1W Performance:
+6.47%
1M Performance:
+10.18%
6M Performance:
-18.79%
1Y Performance:
-19.54%
1-Day Range:
$24.99
$25.56
1-Week Range:
$23.10
$25.66
52-Week Range:
$21.00
$37.85
Enovis Corp Stock (ENOV) Company Profile
Name
Enovis Corp
Sector
Industry
Phone
(302) 252-9160
Address
2711 CENTERVILLE ROAD, WILMINGTON
Compare ENOV vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ENOV
Enovis Corp
|
25.33 | 1.44B | 2.25B | -1.18B | 19.92M | -20.69 |
ABT
Abbott Laboratories
|
101.56 | 175.59B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
341.24 | 132.47B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
87.10 | 113.14B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
64.61 | 94.85B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
78.20 | 45.09B | 6.07B | 1.06B | 1.34B | 1.8063 |
Enovis Corp Stock (ENOV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-06-26 | Initiated | BTIG Research | Buy |
| Oct-03-24 | Initiated | JMP Securities | Mkt Outperform |
| Jun-13-24 | Initiated | JP Morgan | Neutral |
| Feb-13-24 | Initiated | Stephens | Overweight |
| Jan-22-24 | Initiated | UBS | Buy |
| Jan-03-24 | Initiated | William Blair | Outperform |
| Dec-15-23 | Reiterated | Needham | Buy |
| Oct-20-23 | Initiated | ROTH MKM | Buy |
| Jun-26-23 | Initiated | Needham | Buy |
| May-12-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Oct-11-22 | Initiated | Goldman | Buy |
| Sep-12-22 | Initiated | Canaccord Genuity | Buy |
| Sep-12-22 | Initiated | Evercore ISI | Outperform |
| Jun-28-22 | Initiated | Argus | Hold |
| Jun-27-22 | Resumed | Loop Capital | Buy |
| Jun-16-22 | Initiated | Wells Fargo | Equal Weight |
View All
Enovis Corp Stock (ENOV) Latest News
Is It Time To Reconsider Enovis (ENOV) After Recent Share Price Rebound - simplywall.st
Enovis : Proxy Statement 2026 - marketscreener.com
Enovis price target lowered to $39 from $43 at BTIG - TipRanks
BTIG Maintains Enovis Corp(ENOV.US) With Buy Rating, Cuts Target Price to $39 - 富途牛牛
Enovis to Host First Quarter 2026 Results Conference Call on May 7th - marketscreener.com
A Look At Enovis (ENOV) Valuation After Recent Share Price Rebound From A Weaker Year - simplywall.st
Enovis (NYSE: ENOV) HR chief reports 15,552 shares and stock options - Stock Titan
Enovis to Host Q1 2026 Results Call on May 7th - National Today
Enovis will release first-quarter results before a May 7 webcast - Stock Titan
ENOV Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Enovis (NYSE: ENOV) sets 2026 virtual meeting, pay and plan votes - Stock Titan
Evercore Maintains Enovis Corp(ENOV.US) With Buy Rating, Cuts Target Price to $35 - 富途牛牛
Enovis price target lowered to $35 from $36 at Evercore ISI - TipRanks
Enovis Corporation $ENOV Shares Bought by Allspring Global Investments Holdings LLC - MarketBeat
Enovis and Schrodinger Stocks Compared - National Today
Enovis at 2026 CG Musculoskeletal Conference: Strategic Growth and Innovation - Investing.com
Enovis Corporation (ENOV) stock price, news, quote and history - Yahoo Finance Singapore
Director at Enovis (NYSE: ENOV) receives 770-share stock grant - Stock Titan
Enovis Corp (C520.MU) stock price, news, quote and history - Yahoo Finance Singapore
Neeraj Chandola joins Enovis India as HeadHR - ETHRWorld.com
Neeraj Chandola to head human resources for India, at Enovis - HR Katha
Trading Recap: Is Enovis Corporation undervalued by DCF analysis2026 Macro Impact & AI Powered Market Entry Strategies - baoquankhu1.vn
Enovis Sells Dr. Comfort Business to Promus Equity Partners for Up to $60 Million - MSN
Enovis Corporation (ENOV) Stock Forecasts - Yahoo Finance
Enovis Corporation (ENOV) Stock Price Quote Today & Current Price Chart - capital.com
Breakout Zone: What is Enovis Corporations 5 year growth outlookMarket Sentiment Review & Consistent Profit Trade Alerts - baoquankhu1.vn
Trading Recap: What is Enovis Corporations 5 year growth outlookMarket Trend Report & Risk Controlled Daily Plans - baoquankhu1.vn
Enovis (NYSE:ENOV) Upgraded by Wall Street Zen to "Buy" Rating - MarketBeat
Enovis, Neogen, Humana, LifeStance Health Group, and Hims & Hers Health stocks trade down, what you need to know - MSN
Enovis, Neogen, Humana, LifeStance Health Group, and Hims & Hers Health Stocks Trade Down, What You Need To Know - Yahoo Finance
Press Release: Enovis Announces First Quarter 2025 Results - 富途牛牛
[SCHEDULE 13G/A] Enovis CORP Amended Passive Investment Disclosure - Stock Titan
Wall Street analysts see a 100.71% upside in Enovis (ENOV): Can the stock really move this high? - MSN
Enovis Delivers 7% Sales Growth in Q2, Raises Full-Year Outlook - MSN
DAVENPORT & Co LLC Cuts Stock Holdings in Enovis Corporation $ENOV - MarketBeat
Enovis Corporation (NYSE:ENOV) Q4 2025 earnings call transcript - MSN
Wall Street experts predict Enovis (ENOV) could climb by 100.71%: Is such a surge truly possible for the stock? - bitget.com
Wall Street Analysts See a 100.71% Upside in Enovis (ENOV): Can the Stock Really Move This High? - Zacks Investment Research
Enovis (NYSE:ENOV) Stock Rating Lowered by Wall Street Zen - MarketBeat
Enovis Corporation (NYSE:ENOV) Receives Average Recommendation of "Buy" from Analysts - MarketBeat
Tranche Update on Enovis Corporation's Equity Buyback Plan announced on February 16, 2018. - marketscreener.com
Wells Fargo Sticks to Its Buy Rating for Enovis (ENOV) - The Globe and Mail
Enovis (NYSE:ENOV) Rating Increased to Strong-Buy at Wells Fargo & Company - MarketBeat
UBS reiterates Enovis stock Buy rating on growth outlook By Investing.com - Investing.com Australia
UBS reiterates Enovis stock Buy rating on growth outlook - Investing.com
Enovis Corp Stock (ENOV) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.40%
0.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):